After the pandemic, a once-rare Cryptosporidium strain took over Spain's cases

The measures that closed restaurants and emptied swimming pools in 2020 also rewrote the genetics of a gut parasite. A surveillance study published in the US Centers for Disease Control and Prevention journal Emerging Infectious Diseases reports that in Spain, a human-adapted strain of Cryptosporidium hominis that had been recorded only once before the pandemic surged to account for roughly two-thirds of genotyped cases by 2023, displacing the subtype that had dominated the country for two decades [s1].

Cryptosporidium is a diarrhoeal parasite spread through contaminated drinking water, recreational water and fresh produce, and it remains a public health concern across Europe; the European Union reported 1.7 confirmed cases per 100,000 population in 2020, a figure the authors note almost certainly understates the true burden because of underdiagnosis and underreporting [s1]. The genus splits into two epidemiologically distinct species. C. hominis passes mainly from person to person — anthroponotic transmission — while C. parvum is largely zoonotic, moving between animals and people. That difference turned out to matter enormously once human contact was restricted [s1].

A two-decade baseline, then a break

To establish what Spain's parasite population looked like before COVID-19, the investigators pulled together published molecular data and their own reference-laboratory records. Seven studies characterising 806 isolates collected during 2000–2016 showed C. hominis making up 76.1% of cases, and within that species the Ib subtype family accounted for 90.7%, almost all of it the single subtype IbA10G2 (99.6%) [s1]. Their own prepandemic dataset — 389 clinical samples genotyped between December 2013 and December 2019, supplemented by a multicentre study across four tertiary hospitals — told the same story: C. hominis was 85.3% of cases, the Ib family 96.7%, and IbA10G2 96.6% of those [s1]. For twenty years, in other words, one strain overwhelmingly defined human cryptosporidiosis in Spain.

Then came the postpandemic picture. A dedicated multicentre study across eight tertiary hospitals during March–December 2023 yielded 126 clinical samples. C. hominis now made up 96.0% of cases, but its internal composition had been overturned: the If subtype family, previously a bit-player, accounted for 70.2%, and every If isolate belonged to a single subtype, IfA12G1R5 [s1]. The Ib family had shrunk to 22.3%, and within it the historically dominant IbA10G2 had almost vanished, replaced by IbA13G3 at 88.9% [s1].

One strain in, another out

Measured against the long baseline, the shift was stark. The diversity of C. hominis subtypes in 2023 jumped to 10, against two to five historically [s1]. IfA12G1R5 — detected just once in Spain before this period — accounted for 67.5% of cases, while IbA10G2 fell from 79.7% to 1.6% [s1]. Crucially, the zoonotic C. parvum did not follow the same pattern: it stayed comparatively stable and was rarely detected in 2023, producing what the authors call a dual epidemiologic scenario [s1].

The mechanism they propose follows directly from the species' biology. Lockdowns and distancing in 2020 interrupted the person-to-person chains that sustain C. hominis, a disruption documented in earlier time-series work from England, Scotland, Wales and New Zealand, and in a Spanish study of young children with diarrhoea that found C. hominis transmission interrupted while C. parvum carried on [s1]. C. parvum, moving through animals and the environment, was largely insulated from the human behaviour changes. When restrictions relaxed, the gap left in the C. hominis population was filled not by the old resident strain but by hypertransmissible, human-adapted subtypes — chiefly IfA12G1R5 and, less markedly, IbA13G3 — that expanded rapidly into the vacuum [s1].

Why a strain swap is worth watching

The report is built on nonoutbreak, multicentre clinical samples rather than a single outbreak investigation, which is what gives the subtype turnover its weight: this is the parasite's ordinary background circulation, not a one-off cluster [s1]. Whether IfA12G1R5 causes more severe disease than the strain it replaced is not something these data can answer, and the authors do not claim it; the signal is epidemiological, about transmissibility and spread rather than virulence.

The practical lesson is about surveillance capacity. A laboratory that only confirmed Cryptosporidium to the species level would have seen almost nothing change — C. hominis stayed dominant throughout. Only genotyping at the gp60 marker revealed that the population underneath had been almost entirely rebuilt [s1]. As countries weigh how much molecular surveillance to fund for enteric parasites, Spain's experience is a concrete argument for the finer resolution: a pandemic response aimed at a respiratory virus quietly reshaped which strain of a waterborne parasite now spreads most readily between people, and only subtype-level data caught it.